Voyageur Pharmaceuticals (CVE:VM) Shares Up 47.4% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price rose 47.4% during trading on Friday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,229,210 shares were traded during trading, an increase of 502% from the average daily volume of 204,168 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Stock Up 47.4 %

The firm has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm’s 50-day moving average is C$0.08 and its 200 day moving average is C$0.06.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.